# Usana Health Sciences (USNA) — Earnings

USNA · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/usna/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jul 4, 2026 |
| EPS actual | −$0.07 |
| EPS estimate | $0.43 |
| EPS surprise | −116.28% |
| Revenue surprise | −4.99% |
| Revenue | $223.3M |
| Revenue estimate | $235.0M |
| Reported | Aug 4, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/896264/000089626426000056/usna-20260704.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/3b48bd2e-263a-38b1-bce7-5521ca551bc0.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 4, 2026 | $0.43 | −$0.07 | -116.28% | $235.0M | $223.3M |
| Q1 2026 | May 5, 2026 | $0.44 | $0.61 | 38.64% | $241.0M | $250.0M |
| Q4 2025 | Feb 18, 2026 | $0.41 | $0.60 | 46.34% | $226.0M | $226.2M |
| Q3 2025 | Oct 22, 2025 | −$0.15 | −$0.15 | 0.00% | $213.9M | $214.0M |
| Q2 2025 | Jul 22, 2025 | $0.54 | $0.74 | 37.04% | $225.2M | $235.8M |
| Q1 2025 | Apr 22, 2025 | $0.70 | $0.73 | 4.29% | $243.0M | $249.5M |
| Q4 2024 | Feb 25, 2025 | $0.49 | $0.64 | 30.61% | $208.8M | $213.6M |
| Q3 2024 | Oct 22, 2024 | $0.49 | $0.56 | 15.46% | $205.8M | $200.0M |
| Q2 2024 | Jul 23, 2024 | $0.58 | $0.54 | -7.26% | $215.8M | $212.9M |
| Q1 2024 | Apr 30, 2024 | $0.69 | $0.86 | 24.64% | $226.8M | $227.8M |
| Q4 2023 | Feb 6, 2024 | $0.52 | $0.87 | 68.93% | $212.4M | $221.1M |
| Q3 2023 | Oct 24, 2023 | $0.59 | $0.59 | -0.49% | $212.8M | $213.4M |
| Q2 2023 | Jul 25, 2023 | $0.70 | $0.89 | 27.97% | $231.1M | $238.2M |
| Q1 2023 | Apr 25, 2023 | $0.77 | $0.95 | 24.04% | $240.2M | $248.4M |
| Q4 2022 | Feb 7, 2023 | $0.35 | $0.66 | 88.57% | $203.8M | $228.0M |
| Q3 2022 | Oct 25, 2022 | $0.89 | $0.78 | -12.36% | $244.2M | $233.3M |
| Q2 2022 | Jul 26, 2022 | $1.05 | $1.00 | -4.76% | $265.0M | $264.5M |
| Q1 2022 | Apr 26, 2022 | $1.14 | $1.15 | 0.88% | $267.3M | $272.9M |
| Q4 2021 | Feb 8, 2022 | $1.28 | $1.03 | -19.53% | $271.9M | $267.3M |
| Q3 2021 | Oct 26, 2021 | $1.30 | $1.36 | 4.62% | $268.1M | $274.4M |

## Frequently Asked Questions

### When did Usana Health Sciences (USNA) last report earnings?

Usana Health Sciences last reported on Aug 4, 2026, covering fiscal Q2 2026.

### Did USNA beat earnings estimates?

No. Usana Health Sciences reported EPS of −$0.07 for Q2 2026 against a $0.43 estimate — a 116.28% miss.

### How much revenue did USNA report last quarter?

Usana Health Sciences reported $223.3M in revenue for Q2 2026, against a consensus estimate of $235.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).